drugset / Trial / NCT03565484
Antimicrobial Susceptibility Testing Guided Therapy Versus Empirical Therapy for the Rescue Treatment of Helicobacter Pylori Infection
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to assess efficacy of 14-day antimicrobial susceptibility test guided quadruple therapy for the rescue treatment of Helicobacter pylori infection, then comparing it with 14-day personal medication history guided therapy to tell which one has a better performance in both efficacy and safety.
Timeline
- Start
- 2019-01-01
- Primary completion
- 2020-05-30
- Completion
- 2020-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Amoxicillin | Other / unclassified | 1000 mg | — |
| Subject | Clarithromycin | Small molecule | 500 mg | — |
| Subject | Furazolidone | Small molecule | 100 mg | — |
| Subject | Levofloxacin | Small molecule | 500 mg | — |
| Subject | Rabeprazole | Small molecule | 20 mg | — |
| Subject | Tetracycline | Unknown | 500 mg | — |
| Subject | colloidal bismuth pectin | Unknown | 200 mg | — |
| Subject | tinidazole | Small molecule | 500 mg | — |
| Background | Metronidazole | Small molecule | — | — |